News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Daily News In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report Michael O'Riordan January 27, 2022
News Conference News ACC 2021 ‘Enormous’ QoL Improvements With Mavacamten in HCM Shelley Wood May 15, 2021
News Daily News Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM Shelley Wood May 11, 2020
News Daily News Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes Michael O'Riordan August 09, 2018